AZ-UNIVERSAL-ELECTRONICS
1.5.2020 22:17:07 CEST | Business Wire | Press release
Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in universal control and sensing technologies for the smart home, has received five 2020 Red Dot Awards , one of the most prestigious international design awards, in the Product Design category. Products from UEI’s consumer brand, One For All , won four of the five awards.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200501005501/en/
The award-winning products were designed by UEI’s design team in the Netherlands, part of the global Designovation team which creates product designs based on user insights and innovative technology. Led by Rex Xu, Director of Design and User Experience, the team in the Netherlands works closely with UEI’s design offices in the U.S. and Hong Kong to ensure all products truly reflect global trends in design and technology.
“Winning five Red Dot Awards is a true honor and a testament to our design team’s exceptional talent,” said Xu. “Design is one of UEI’s key differentiators and we always create our designs with the user experience in mind. The team works under clear guiding principles of our successful Designovation formula which creates honest product designs based on true consumer insights applying the latest technology and design trends.”
Two of One For All’s TV stands were recognized with 2020 Red Dot Awards:
The Tripod Universal TV Stand fits televisions up to 65 inches, can swivel a true 360 degrees and blends into any corner with natural chestnut or oak wooden legs for a modern look.
The One For All Falcon Universal TV Stand supports televisions up to 70 inches and is designed to accommodate soundbars, streaming boxes and game consoles connected to the television. With its fabric skinned storage cover at the back of the television, cables are completely out of sight.
One For All also won two Red Dot awards for its market-leading digital TV antennas:
The Amplified Indoor TV Antenna features leading reception technology in a beautiful fabric skinned housing. With its homey design, it can hang on the wall, stand or lie flat while allowing for maximum channel coverage.
The darker colored Amplified Indoor TV Antenna offers a stylish look and unique signal level indicator that blends into the fabric housing. This ensures optimal signal and maximum number of available channels.
The fifth Red Dot Award is for UEI’s Kita premium Android TV voice remote control specifically designed for service providers with advanced video services that want a simplified user experience. In addition to supporting voice control and dedicated streaming app keys, this remote control features adaptive control which interacts with the television and only shows users the keys they need. It uses rechargeable technology in a slim housing, saving multiple batteries over the life of the product.
For more information about how to purchase these award-winning products, contact info@uei.com .
In 2019 One For All won Red Dot Awards for its Amplified Indoor Ball Design Antenna and One For All FLUX Gas Spring TV Wall Mount. With origins dating back to 1955, the Red Dot is established internationally as one of the most sought-after quality marks for outstanding design with annual competitions for Product Design, Brands and Communication, and Design Concept. Red Dot Award submissions are evaluated by a jury of independent designers, design professors and journalists.
All trademarks appearing herein are the property of their respective owners.
One For All is a registered trademark of Universal Electronics Inc.
About Universal Electronics Inc.
Founded in 1986, Universal Electronics Inc. (NASDAQ: UEIC) is the global leader in universal control and sensing technologies for the smart home. The company designs, develops, manufactures and ships over 500 innovative products that are used by the world’s leading brands in the consumer electronics, subscription broadcast, security, home automation, hospitality and climate control markets. For more information, visit www.uei.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200501005501/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 15:37:00 CEST | Press release
The new SpeechLive Legal AI Assistant reduces the administrative burden on legal professionals through customizable document drafting powered by speech recognition tuned for legal terminology Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom